EPISODE · Nov 16, 2007 · 13 MIN
The Lancet: November 16, 2007
from Listen to The Lancet · host The Lancet
Arne Astrup from the University of Copenhagen, Denmark, discusses a meta-analysis highlighting how the anti-obesity drug rimonabant is associated with an increased risk of depressive disorders. The meta-analysis pooled data from four randomised trials from the RIO (rimonabant in obesity) programme.
Embed this episode
NOW PLAYING
The Lancet: November 16, 2007
0:00
13:40
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet?
This episode is 13 minutes long.
When was this Listen to The Lancet episode published?
This episode was published on November 16, 2007.
Can I download this Listen to The Lancet episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!